Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite.
Numerous antibodies that neutralize SARS-CoV-2 have been identified, and these generally target either the receptor-binding domain (RBD) or the N-terminal domain (NTD) of the viral spike. While RBD-directed antibodies have been extensively studied, far less is known about NTD-directed antibodies. Here, we report cryo-EM and crystal structures for seven potent NTD-directed neutralizing antibodies in complex with spike or isolated NTD. These structures defined several antibody classes, with at least one observed in multiple convalescent donors. The structures revealed that all seven antibodies target a common surface, bordered by glycans N17, N74, N122, and N149. This site-formed primarily by a mobile β-hairpin and several flexible loops-was highly electropositive, located at the periphery of the spike, and the largest glycan-free surface of NTD facing away from the viral membrane. Thus, in contrast to neutralizing RBD-directed antibodies that recognize multiple non-overlapping epitopes, potent NTD-directed neutralizing antibodies appear to target a single supersite.
['Cerutti|Gabriele|G|', 'Guo|Yicheng|Y|', 'Zhou|Tongqing|T|', 'Gorman|Jason|J|', 'Lee|Myungjin|M|', 'Rapp|Micah|M|', 'Reddem|Eswar R|ER|', 'Yu|Jian|J|', 'Bahna|Fabiana|F|', 'Bimela|Jude|J|', 'Huang|Yaoxing|Y|', 'Katsamba|Phinikoula S|PS|', 'Liu|Lihong|L|', 'Nair|Manoj S|MS|', 'Rawi|Reda|R|', 'Olia|Adam S|AS|', 'Wang|Pengfei|P|', 'Zhang|Baoshan|B|', 'Chuang|Gwo-Yu|GY|', 'Ho|David D|DD|', 'Sheng|Zizhang|Z|', 'Kwong|Peter D|PD|', 'Shapiro|Lawrence|L|']
D057134:Antibodies, Neutralizing D000914:Antibodies, Viral D006801:Humans D009154:Mutation D011487:Protein Conformation D000072417:Protein Domains D000086402:SARS-CoV-2 D064370:Spike Glycoprotein, Coronavirus
SARS-CoV-2 neutralizing antibody N-terminal domain antibody class COVID-19 antigenic supersite multi-donor antibody